Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W1QA
|
|||
| Former ID |
DIB006547
|
|||
| Drug Name |
GC-1102
|
|||
| Synonyms |
Hepabig; HuS10; HBIG, Korea Green Cross; Hepabig-Gene; Recombinant hepatitis B virus immune globulin, Korea Green Cross; Recombinant anti-HBV monoclonal antibody, Green Cross
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [1] | |
| Company |
Green Cross Corp
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02304315) A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.